EditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comAs every part of the drug discovery and development process moves toward automation to improve processing speeds and information accuracy, advanced image analysis solutions play a significant role too. As opposed to traditional human-based methods, fully automated image analysis solutions can process hundreds of images in an hour along with delivering actionable insights instantly. More importantly, automated analysis lowers backend drug development costs and in turn, reduces the prices at which drugs are sold to patients.At the same time, effective analysis of image data depends on the quality of the initial images, and hence, pre-processing of images after they are automatically acquired is necessary. Background fluorescence, which is a prevalent problem with microscopic image acquisition, must be appropriately corrected by solution providers to facilitate the subsequent image segmentation and quantification steps. Also, image analysis solutions that feature region-based segmentation capabilities can further pave the way for quicker and more efficient drug discovery.Beyond drug discovery and development, image analysis also helps identify defects in drugs as pharmaceutical companies need to ensure that the drugs delivered to patients are free of side effects. It involves detecting variations in color, size, and shape as well as quantitative analysis of drug efficacy markers. With various other impactful applications of image analysis in the pharmaceutical industry, organizations must wisely select solutions and services that best fulfill their requirements. To assist them with the same, this edition of Pharma Tech Outlook features some of the topmost image analysis solution and service providers.Do let us know your thoughts.Intelligent Image Analysis Expedites Drug DiscoveryCopyright © 2019 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.JUNE - 24 - 2019, Vol 05 - Issue 08 Published by ValleyMedia Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerAsher BlakeEditorial StaffAaron Pierce Ava GarciaJenna VegasAbhilash Punnoliparambil Justin SmithPaul BarberSalesJohn Bocardojohn@pharmatechoutlook.comPhone: 510.996.5173sales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:Contact Us:Phone:510.556.2402, Fax:510-894-8405Scott JuasyTECH OUTLOOKTECH OUTLOOK
< Page 5 | Page 7 >